COVID-19合并急性缺血性卒中的特征与结局:全球COVID-19卒中登记研究
该研究汇总16国28中心174例实验室确诊COVID-19合并急性缺血性卒中患者,并与2003-2019年洛桑卒中登记中非COVID-19患者进行1:1倾向评分匹配。匹配分析显示COVID-19患者卒中更严重、功能结局更差且死亡风险更高。
要点
- COVID-19合并急性缺血性卒中患者入院卒中严重程度更高
- 匹配分析显示COVID-19患者严重残疾和死亡风险显著增加
- 需警惕COVID-19相关卒中的不良预后并优化急诊卒中路径
核心结论
- COVID-19相关缺血性卒中比非COVID-19缺血性卒中更严重,功能结局更差且死亡率更高。
研究设计与样本
- 多中心队列研究,汇总16国28中心连续住院的实验室确诊COVID-19合并急性缺血性卒中患者174例。
- 与洛桑急性卒中登记与分析登记中2003至2019年非COVID-19患者进行1:1倾向评分匹配分析。
主要发现
- COVID-19患者中位年龄71.2岁,女性占37.9%,中位NIHSS为10(IQR 4-18)。
- 匹配样本中COVID-19患者中位NIHSS高于非COVID-19患者(10 vs 6),P=0.03,较高NIHSS的OR为1.69(95%CI 1.08-2.65)。
- 174例中死亡48例(27.6%),其中22例归因于COVID-19,26例归因于卒中。
- 96例存活者有残疾信息,其中49例(51%)出院时存在严重残疾。
- 倾向评分匹配人群(n=330)中,COVID-19患者严重残疾风险更高(中位mRS 4 vs 2,P<0.001),死亡OR为4.3(95%CI 2.22-8.30)。
临床怎么用
- 临床医生应认识到COVID-19合并急性缺血性卒中患者卒中更严重且预后更差。
- 需据此预警卒中诊疗团队并优化院前及院内急性卒中患者路径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent case-series of small size implied a pathophysiological association between coronavirus disease 2019 (COVID-19) and severe large-vessel acute ischemic stroke. Given that severe strokes are typically associated with poor prognosis and can be very efficiently treated with recanalization techniques, confirmation of this putative association is urgently warranted in a large representative patient cohort to alert stroke clinicians, and inform pre- and in-hospital acute stroke patient pathways. We pooled all consecutive patients hospitalized with laboratory-confirmed COVID-19 and acute ischemic stroke in 28 sites from 16 countries. To assess whether stroke severity and outcomes (assessed at discharge or at the latest assessment for those patients still hospitalized) in patients with acute ischemic stroke are different between patients with COVID-19 and non-COVID-19, we performed 1:1 propensity score matching analyses of our COVID-19 patients with non-COVID-19 patients registered in the Acute Stroke Registry and Analysis of Lausanne Registry between 2003 and 2019. Between January 27, 2020, and May 19, 2020, 174 patients (median age 71.2 years; 37.9% females) with COVID-19 and acute ischemic stroke were hospitalized (median of 12 patients per site). The median National Institutes of Health Stroke Scale was 10 (interquartile range [IQR], 4-18). In the 1:1 matched sample of 336 patients with COVID-19 and non-COVID-19, the median National Institutes of Health Stroke Scale was higher in patients with COVID-19 (10 [IQR, 4-18] versus 6 [IQR, 3-14]), P=0.03; (odds ratio, 1.69 [95% CI, 1.08-2.65] for higher National Institutes of Health Stroke Scale score). There were 48 (27.6%) deaths, of which 22 were attributed to COVID-19 and 26 to stroke. Among 96 survivors with available information about disability status, 49 (51%) had severe disability at discharge. In the propensity score-matched population (n=330), patients with COVID-19 had higher risk for severe disability (median mRS 4 [IQR, 2-6] versus 2 [IQR, 1-4], P<0.001) and death (odds ratio, 4.3 [95% CI, 2.22-8.30]) compared with patients without COVID-19. Our findings suggest that COVID-19 associated ischemic strokes are more severe with worse functional outcome and higher mortality than non-COVID-19 ischemic strokes.
引用
- Ntaios G, Michel P, Georgiopoulos G, et al. Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry. Stroke. 2020. PMID: 32787707. doi:10.1161/STROKEAHA.120.031208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。